LRH-1 as a target for the development of new breast cancer therapies
Estrogen drives the growth and development of estrogen receptor alpha (ERα) positive breast cancer and ERα is the target for hormonal therapies that inhibit its activity. A substantial proportion of patients become resistant to these therapies, demonstrating a need for new therapies. Gene expression...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2014
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733018 |